{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:33:40Z","timestamp":1795210420917,"version":"4.10.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41431-025-01939-1","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T05:13:39Z","timestamp":1759468419000},"page":"296-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluating DNA methylation episignatures as a first-tier diagnostic test in individuals with suspected genetic disorders"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1924-6695","authenticated-orcid":false,"given":"Tinatin","family":"Tkemladze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakha","family":"Bregvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eka","family":"Kvaratskhelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elene","family":"Abzianidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Demain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-6606","authenticated-orcid":false,"given":"Jennifer","family":"Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-0016","authenticated-orcid":false,"given":"Bekim","family":"Sadikovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Banka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1939_CR1","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1542\/peds.2014-1839","volume":"134","author":"JB Moeschler","year":"2014","unstructured":"Moeschler JB, Shevell M. Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:e903\u201318.","journal-title":"Pediatrics"},{"key":"1939_CR2","first-page":"100075","volume":"3","author":"MA Levy","year":"2021","unstructured":"Levy MA, McConkey H, Kerkhof J, Barat-Houari M, Bargiacchi S, Biamino E, et al. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders. HGG Adv. 2021;3:100075.","journal-title":"HGG Adv"},{"key":"1939_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ajhg.2021.04.022","volume":"108","author":"E Aref-Eshghi","year":"2021","unstructured":"Aref-Eshghi E, Kerkhof J, Pedro VP, France GD, Barat-Houari M, Ruiz-Pallares N, et al. Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am J Hum Genet. 2021;108:1161\u20133.","journal-title":"Am J Hum Genet"},{"key":"1939_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41436-020-01096-4","volume":"23","author":"B Sadikovic","year":"2021","unstructured":"Sadikovic B, Levy MA, Kerkhof J, Aref-Eshghi E, Schenkel L, Stuart A, et al. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders. Genet Med. 2021;23:1065\u201374.","journal-title":"Genet Med"},{"key":"1939_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajhg.2017.12.008","volume":"102","author":"E Aref-Eshghi","year":"2018","unstructured":"Aref-Eshghi E, Rodenhiser DI, Schenkel LC, Lin H, Skinner C, Ainsworth P, et al. Genomic DNA methylation signatures enable concurrent diagnosis and clinical genetic variant classification in neurodevelopmental syndromes. Am J Hum Genet. 2018;102:156\u201374.","journal-title":"Am J Hum Genet"},{"key":"1939_CR6","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1093\/hmg\/ddaa144","volume":"29","author":"B Sadikovic","year":"2020","unstructured":"Sadikovic B, Levy MA, Aref-Eshghi E. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders. Hum Mol Genet. 2020;29:R27\u2013R32.","journal-title":"Hum Mol Genet"},{"key":"1939_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jmoldx.2016.06.005","volume":"18","author":"LC Schenkel","year":"2016","unstructured":"Schenkel LC, Schwartz C, Skinner C, Rodenhiser DI, Ainsworth PJ, Pare G, et al. Clinical validation of fragile X syndrome screening by DNA methylation array. J Mol Diagn. 2016;18:834\u201341.","journal-title":"J Mol Diagn"},{"key":"1939_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ajhg.2020.01.019","volume":"106","author":"E Aref-Eshghi","year":"2020","unstructured":"Aref-Eshghi E, Kerkhof J, Pedro VP, Groupe DI France, Barat-Houari M, Ruiz-Pallares N, et al. Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am J Hum Genet. 2020;106:356\u201370.","journal-title":"Am J Hum Genet"},{"key":"1939_CR9","unstructured":"EpiSign. EpiSign conditions list. London (ON): EpiSign; 2024. https:\/\/episign.com\/wp-content\/uploads\/2024\/06\/EpiSign-Conditions-List.pdf"},{"key":"1939_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gim.2021.08.007","volume":"24","author":"J Kerkhof","year":"2022","unstructured":"Kerkhof J, Squeo GM, McConkey H, Levy MA, Piemontese MR, Castori M, et al. DNA methylation episignature testing improves molecular diagnosis of Mendelian chromatinopathies. Genet Med. 2022;24:51\u201360.","journal-title":"Genet Med"},{"key":"1939_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/15592294.2018.1514230","volume":"13","author":"L Fontana","year":"2018","unstructured":"Fontana L, Bedeschi MF, Maitz S, Cereda A, Far\u00e9 C, Motta S, et al. Characterization of multi-locus imprinting disturbances and underlying genetic defects in patients with chromosome 11p15.5 related imprinting disorders. Epigenetics. 2018;13:897\u2013909.","journal-title":"Epigenetics"},{"key":"1939_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0649-6","volume":"11","author":"IM Krzyzewska","year":"2019","unstructured":"Krzyzewska IM, Alders M, Maas SM, Bliek J, Venema A, Henneman P, et al. Genome-wide methylation profiling of Beckwith-Wiedemann syndrome patients without molecular confirmation after routine diagnostics. Clin Epigenetics. 2019;11:53.","journal-title":"Clin Epigenetics"},{"key":"1939_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101075","volume":"26","author":"J Kerkhof","year":"2024","unstructured":"Kerkhof J, Rastin C, Levy MA, Relator R, McConkey H, Demain L, et al. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases. Genet Med. 2024;26:101075.","journal-title":"Genet Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01939-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01939-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01939-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:45:52Z","timestamp":1769769952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01939-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01939-1","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.S. is a shareholder in EpiSign Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by local Institutional Review Board. Written and oral consent from all individuals\u2019 legal representatives was obtained. Consent was obtained to publish identifying photos.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}